Professor, Medical School/School of Public Health
Sofia D. Merajver is a physician-scientist with a translational focus on integrating molecular genetics of breast cancer with clinical, social, and environmental determinants of outcomes in the global stage for women at high risk for breast cancer and women affected with aggressive breast cancer phenotypes. She is the founder and director of the U-M Breast and Ovarian Cancer Risk Evaluation Program and a scientific leader of the Breast Oncology Program. Dr. Merajver is engaged with clinical translational research that tests prevention and therapeutic interventions and educational tools to improve cancer outcomes globally.
She has supervised graduate and undergraduate students and mentored postdoctoral fellows and junior faculty who have entered research careers in molecular and psychosocial aspects of cancer outcomes in special populations in the US and Africa.